Emerging Risk Markers - Lp(a) and Coronary Calcium

Canadian Collaborative Research Network

K. Nasir

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Carbs: Are They the Enemy? Processed vs Unprocessed vs None

James O'Keefe

Ambulatory Blood Pressure Monitoring

William White

Dietary Cholesterol

Neal Barnard

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Obesity and Diabetes in Children

Ilene Fennoy

Intermittent Fasting: What Is the Evidence for Efficacy and Cardiome…

4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention

J. Kane

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Dairy: What's the Data Say

Monica Aggarwal

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston